Beconase Aqueous Nasal Spray Special Precautions

Infections of the nasal passages and paranasal sinuses should be appropriately treated but do not constitute a specific contraindication to treatment with BECONASE Aqueous Nasal Spray.
Care must be taken while transferring patients from systemic steroid treatment to BECONASE Aqueous Nasal Spray if there is any reason to suppose that their adrenal function is impaired.
Systemic effects with nasal corticosteroids have been reported, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations.
If recommended doses of intranasal beclomethasone are exceeded or if individuals are particularly sensitive or predisposed by virtue of recent systemic steroid therapies, systemic effects may occur including reduction in growth velocity. Visual disturbances has been reported, including cataract, glaucoma or central serous chorioretinopathy.
Although BECONASE Aqueous Nasal Spray will control seasonal allergic rhinitis in most cases, an abnormally heavy challenge of summer allergens, in certain instances, necessitate appropriate additional therapy particularly to control eye symptoms.
Effects on Ability to Drive and Use Machines: None reported.